CD3+/TCRαβ+ CD4-/CD8- ‘double negative’ (DN) T-cells were 0.25 %, making a diagnosis of autoimmune lymphoproliferative syndrome (ALPS) less likely. This evidence concerns the gene CD4 and autoimmune lymphoproliferative syndrome.